| 摘要 |
<p>This invention relates to pharmaceutical compositions comprising combinations of GABA agonists, a prodrug thereof of a pharmaceutically acceptable salt of said GABA agonist or said prodrug and a SDI, a prodrug thereof of a pharmaceutically acceptable salts of said SDI or said prodrug, kits containing such combinations and methods of using such combinations to treat mammals, including humans, suffering from diabetic complication such as diabetic neuropathy, diabetic nephropathy, diabetic cardiomyopathy, diabetic retinopathy, diabetic macroangiopathy, diabetic macroangiopathy, cataracts or foot ulcers. 15 claims</p> |
